You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 25, 2026

Profile for Austria Patent: 374777


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Austria Patent: 374777

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Start Trial Dec 13, 2029 Jazz ZEPZELCA lurbinectedin
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Patent AT374777: Scope, Claims, and Landscape Analysis

Last updated: February 27, 2026

What Does Patent AT374777 Cover?

Patent AT374777, pertaining to a pharmaceutical compound or method, claims a specific formulation or process but lacks publicly available, detailed claim language in open sources. Based on typical patent structures, the patent likely protects a novel medication, its formulation, the method of manufacturing, or its use for treating particular conditions.

General Patent Components:

  • Title: Usually indicates the core invention, e.g., a specific active compound, dosage form, or therapeutic method.
  • Abstract: Summarizes the invention.
  • Claims: Define the scope of protection; may include independent and dependent claims.
  • Description: Details the invention, prior art distinctions, and embodiments.

In the absence of the official published claims, an inference indicates the scope likely covers a specific novel combination of therapeutic agents, a unique delivery system, or a specific pharmacological application.


What Are the Claims Likely Comprising?

Typical Claim Structure for a Pharmaceutical Patent

  • Independent claims describe the core invention, such as a compound, formulation, or use.
  • Dependent claims narrow the scope, adding specifics like dosage, formulation, or method steps.

Expected Claim Features:

  • Composition of matter (e.g., a chemical compound or combination).
  • Method of use (therapy for a specific disease).
  • Formulation details (e.g., controlled-release system).
  • Manufacturing process.

Example Hypothetical Claims:

  • A pharmaceutical composition comprising compound X in combination with compound Y for the treatment of disease Z.
  • A method for preparing a stable formulation of compound X.
  • Use of compound X for treating disease Z.

Patent Landscape Analysis

Key Jurisdictions

  • EU-wide protection via Austria’s patent system.
  • Similar patents in the European Patent Office (EPO) jurisdiction.
  • Global patents possibly filed under PCT applications.

Patent Family and Priority

  • AT374777 likely claims priority from an earlier application, possibly filed in Austria or via PCT.
  • Patent family members may exist, covering countries like Germany, France, the UK, the US, and Asian jurisdictions.

Patent Duration and Maintenance

  • Granted patents in Austria last 20 years from the filing date, typically maintained via fee payments.
  • The filing date and grant date are crucial for assessing remaining patent life.

Competitive Landscape

  • Several patents internationally may cover similar compounds or methods.
  • Competitors may hold patents in the same therapeutic space, influencing freedom-to-operate.

Patent Analysis Tools

  • Use EPO espacenet, Patentscope, or commercial IP databases.
  • Assess patent family members, citations, and legal status.

Claims and Landscape Challenges

Potential Overlaps

  • Similar patents in the same therapeutic space could lead to infringement or validity challenges.
  • Prior art references can limit claim scope or prompt patent narrowing.

Opportunities

  • Narrow claims can create licensing potential.
  • Patent term extension or supplementary protection certificate (SPC) strategies can prolong exclusivity.

Key Takeaways

  • Patent AT374777 likely covers a specific pharmaceutical composition or use, with a scope defined primarily by its claims.
  • Its protection may extend across Austria and possibly broader via family members.
  • The competitive landscape involves patents related to similar compounds, formulations, or therapeutic methods.
  • Detailed claims analysis requires access to the official patent documents, typically via patent databases like EPO or national patent offices.
  • Strategic considerations include the strength of claims, remaining patent life, and potential for licensing or enforcing.

FAQs

1. How can I access the full patent document for AT374777?
Official patent documents are available through the Austrian Patent Office or international patent databases such as EPO espacenet or WIPO Patentscope.

2. What factors influence the scope of patent AT374777?
Claim language, claim dependencies, and the description all define the protection scope; broader claims cover more, but are harder to defend.

3. Are there similar patents in the same therapeutic area?
Yes. Similar patents are common in fields like neurology, oncology, and infectious diseases. Patent landscape analysis tools help identify them.

4. How does the patent landscape impact competitors?
It reveals freedom-to-operate risks, patent expiration timelines, and licensing opportunities.

5. Can the claims of AT374777 be challenged?
Yes. Validity challenges may be based on prior art or obviousness; enforcement depends on claim scope and patent defensibility.


References

  1. European Patent Office. (2023). espacenet patent database. https://worldwide.espacenet.com
  2. World Intellectual Property Organization. (2023). Patent scope database. https://patentscope.wipo.int
  3. Austrian Patent Office. (2023). Patent record. https://www.patentamt.at

(Note: Specific claim text and detailed legal status should be retrieved from official patent documents.)

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.